Correlation Between Circulating Fibrocytes and Dermal Thickness in Limited Cutaneous Systemic Sclerosis Patients: a Pilot Study

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 2019 May 7

PMID 31056725

Citations 39

Authors

Barbara Ruaro

Stefano Soldano

Vanessa Smith

Sabrina Paolino

Paola Contini

Paola Montagna

Carmen Pizzorni

Andrea Casabella

Samuele Tardito

Alberto Sulli

Maurizio Cutolo

Affiliations

Soon will be listed here.

Abstract

The objective is to detect any possible correlation between the modified Rodnan skin score (mRSS) and dermal thickness (DT) measured by skin high-frequency ultrasound (US) and the percentage of circulating fibrocytes in patients with limited cutaneous systemic sclerosis (lcSSc). Eight lcSSc patients and five healthy subjects (control group, CNT) were enrolled. The skin involvement was evaluated by mRSS and US (18 and 22 MHz probes) in all 13 subjects in the 17 standard skin areas evaluated by mRss. Circulating fibrocytes were isolated from the peripheral blood mononuclear cells (PBMCs) of all lcSSc patients and the CNT group to analyze their percentage at baseline time (T0) when the experiments started with PBMCs' isolation and collection and after 8 days of culture (T8). Non-parametric tests were used for the statistical analysis. A positive correlation between the percentage of circulating fibrocytes at T0, mRSS (p = 0.04 r = 0.96), and DT-US, evaluated by the 22 MHz and the 18 MHz probes (p = 0.03, r = 0.66 and p = 0.05, r = 0.52, respectively), was observed in lcSSc patients. Conversely, at T8, there was no correlation (p > 0.05) between these parameters in lcSSc group. In the CNT group, no correlations between mRSS or DT-US and the percentage of circulating fibrocytes were observed both at T0 and T8. The study shows the presence of a significant relationship between the percentage of circulating fibrocytes and DT, as evidenced by both mRSS and US, in limited cutaneus SSc. This observation may well suggest the reasonable hypothesis of a crucial contribution of circulating fibrocytes to skin fibrosis progression, which might be considered as further biomarkers.

Citing Articles

Skin Ultrasound Assessment of Patients with Systemic Scleroderma-An Observational Study.

Palici C, Ciurea P, Bita C, Barbulescu A, Florescu A, Musetescu A J Pers Med. 2024; 14(7).

PMID: 39063988 PMC: 11278380. DOI: 10.3390/jpm14070734.

Interferon type I signature associated with skin disease in juvenile dermatomyositis.

Raupov R, Suspitsin E, Preobrazhenskaya E, Kostik M Front Med (Lausanne). 2024; 11:1214920.

PMID: 38420360 PMC: 10899462. DOI: 10.3389/fmed.2024.1214920.

Reproducibility of pulmonary function tests in patients with systemic sclerosis.

Jacquerie P, Andre B, De Seny D, Henket M, Giltay L, Ernst M Sci Rep. 2023; 13(1):18960.

PMID: 37923803 PMC: 10624913. DOI: 10.1038/s41598-023-45881-y.

Cellular Transdifferentiation: A Crucial Mechanism of Fibrosis in Systemic Sclerosis.

Jimenez S, Piera-Velazquez S Curr Rheumatol Rev. 2023; 20(4):388-404.

PMID: 37921216 DOI: 10.2174/0115733971261932231025045400.

Biomarkers in Systemic Sclerosis: An Overview.

Di Maggio G, Confalonieri P, Salton F, Trotta L, Ruggero L, Kodric M Curr Issues Mol Biol. 2023; 45(10):7775-7802.

PMID: 37886934 PMC: 10604992. DOI: 10.3390/cimb45100490.

References

Cutolo M, Sulli A, Pizzorni C, Accardo S . Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000; 27(1):155-60. View

Abe R, Donnelly S, Peng T, Bucala R, Metz C . Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001; 166(12):7556-62. DOI: 10.4049/jimmunol.166.12.7556. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Moore T, Lunt M, McManus B, Anderson M, Herrick A . Seventeen-point dermal ultrasound scoring system--a reliable measure of skin thickness in patients with systemic sclerosis. Rheumatology (Oxford). 2003; 42(12):1559-63. DOI: 10.1093/rheumatology/keg435. View

Phillips R, Burdick M, Hong K, Lutz M, Murray L, Xue Y . Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004; 114(3):438-46. PMC: 484979. DOI: 10.1172/JCI20997. View

Mori L, Bellini A, Stacey M, Schmidt M, Mattoli S . Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res. 2005; 304(1):81-90. DOI: 10.1016/j.yexcr.2004.11.011. View

Moore B, Kolodsick J, Thannickal V, Cooke K, Moore T, Hogaboam C . CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol. 2005; 166(3):675-84. PMC: 1780139. DOI: 10.1016/S0002-9440(10)62289-4. View

Russo R, Medbury H, Guiffre A, Englert H, Manolios N . Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma. Clin Rheumatol. 2006; 26(7):1136-41. DOI: 10.1007/s10067-006-0461-5. View

Czirjak L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst D . The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis. 2007; 66(7):966-9. PMC: 1955103. DOI: 10.1136/ard.2006.066530. View

10.

Sulli A, Secchi M, Pizzorni C, Cutolo M . Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis. 2007; 67(6):885-7. DOI: 10.1136/ard.2007.079756. View

11.

Bucala R . Circulating fibrocytes: cellular basis for NSF. J Am Coll Radiol. 2008; 5(1):36-9. DOI: 10.1016/j.jacr.2007.08.016. View

12.

Eyden B . The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med. 2008; 12(1):22-37. PMC: 3823470. DOI: 10.1111/j.1582-4934.2007.00213.x. View

13.

Keeley E, Mehrad B, Strieter R . The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders. Thromb Haemost. 2009; 101(4):613-8. PMC: 3353523. View

14.

Sulli A, Soldano S, Pizzorni C, Montagna P, Secchi M, Villaggio B . Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. J Rheumatol. 2009; 36(6):1235-9. DOI: 10.3899/jrheum.081030. View

15.

Krieg T, Takehara K . Skin disease: a cardinal feature of systemic sclerosis. Rheumatology (Oxford). 2009; 48 Suppl 3:iii14-8. DOI: 10.1093/rheumatology/kep108. View

16.

Strieter R, Keeley E, Hughes M, Burdick M, Mehrad B . The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol. 2009; 86(5):1111-8. PMC: 2774878. DOI: 10.1189/jlb.0309132. View

17.

Kaldas M, Khanna P, Furst D, Clements P, Wong W, Seibold J . Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials. Rheumatology (Oxford). 2009; 48(9):1143-6. PMC: 2734267. DOI: 10.1093/rheumatology/kep202. View

18.

Kaloudi O, Bandinelli F, Filippucci E, Conforti M, Miniati I, Guiducci S . High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis. Ann Rheum Dis. 2009; 69(6):1140-3. DOI: 10.1136/ard.2009.114843. View

19.

Chu P, Mariani J, Finch S, McMullen J, Sadoshima J, Marshall T . Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol. 2010; 176(4):1735-42. PMC: 2843465. DOI: 10.2353/ajpath.2010.090574. View

20.

Cutolo M, Sulli A, Smith V . Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol. 2010; 6(10):578-87. DOI: 10.1038/nrrheum.2010.104. View